Nephrology Doctors in Columbus, OH Accepting Medicare

43 Nephrology doctors found. Showing 41 - 43

Brad H. Rovin, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 543 Taylor Ave, Columbus, OH 43203 Phone: 614-293-4997    Fax: 614-293-3073

Dr. Lakhan K. Saha, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 285 E State St, Suite 360, Columbus, OH 43215 Phone: 614-621-0101    Fax: 614-621-1930

Rosemarie Lin Shim, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 985 W 3rd Ave, Columbus, OH 43212 Phone: 614-291-0022    Fax: 614-291-6687

News Archive

Brain activity rapidly changes in olfactory regions following odor deprivation

Has a summer cold or mold allergy stuffed up your nose and dampened your sense of smell? We take it for granted that once our nostrils clear, our sniffers will dependably rebound and alert us to a lurking neighborhood skunk or a caramel corn shop ahead. That dependability is no accident. It turns out the brain is working overtime behind the scenes to make sure the sense of smell is just as sharp after the nose recovers.

Celling Technologies and SpineSmith team up to research adipose tissue derived stem cell applications

Celling Technologies, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc. to research potential applications for adipose tissue derived adult stem cells. SpineSmith acquired the global rights in spine for Tissue Genesis' adipose (fat) tissue derived stem cell technology in November of 2007.

Study finds potential target for migraine therapy

Migraines affect millions of people worldwide, often lasting days and severely disrupting lives. More than simply super-intense headaches, some migraines actually result from pathological excitation of neurons in the brain.

Drug sellers, benefit managers poise for court-ordered price cuts

"A forthcoming rollback of benchmark drug prices - a court-approved move meant to benefit consumers - should have little effect on the bottom line for pharmacy-benefit managers or their clients, as companies have taken protective steps," the Wall Street Journal reports. Pharmacies, however, worry the 4 percent reduction in benchmark prices could result in Medicaid reductions. Benefit managers initially opposed the cut, but say they have adjusted contracts to make up for it.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3(current)